RecruitingNCT01277419

German Spondyloarthritis Inception Cohort

Sponsor

Charite University, Berlin, Germany

Enrollment

1,000 participants

Start Date

Jul 1, 2000

Study Type

OBSERVATIONAL

Conditions

Ulcerative Colitis (UC)Crohn Disease (CD)Non-radiographic Axial Spondyloarthritis (Nr-axSpA)Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)Axial Psoriatic Arthritis (axPsA)Acute Anterior Uveitis (AAU)

Summary

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA including ankylosing spondylitis (AS, also known as radiographic axial spondyloarthritis) and non-radiographic axial SpA. The objectives of GESPIC are to learn about the course of SpA during the very early stage of the disease, to appropriately assess the outcome including radiographic progression of patients after several years of follow-up, to identify outcome predictors, to assess quality of life, function, and costs (direct and indirect costs). GESPIC has been recently expanded to recruit patients with other forms of SpA / conditions associated with SpA: acute anterior uveitis, Crohn's disease as well as with psoriasis / axial psoriatic arthritis.

Eligibility

Plain Language Summary

Simplified for easier understanding

This German inception cohort study follows patients newly diagnosed with spondyloarthritis — a group of inflammatory conditions affecting the spine, joints, skin, eyes, and gut — to understand how these diseases progress and respond to treatment over time. **You may be eligible if...** - You have a confirmed diagnosis of axial spondyloarthritis (inflammatory arthritis primarily affecting the spine and pelvis) or juvenile spondyloarthritis - You have a confirmed diagnosis of Crohn's disease - You have a confirmed diagnosis of acute anterior uveitis (sudden eye inflammation) - You have a confirmed diagnosis of psoriatic arthritis with spinal involvement **You may NOT be eligible if...** - No formal exclusion criteria are specified — eligibility is based on meeting one of the diagnosis criteria above Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.